Key Highlights
- New iron-based photocatalyst developed by researchers at Nagoya University.
- Catalyst activated by blue light, replacing rare and expensive metals.
- Uses fewer costly chiral ligands compared to previous designs.
- Maintains precise control over three-dimensional molecular structures.
- Represents a significant milestone in drug synthesis efficiency.


